Indar has pioneered Ukraine's export of high value-added pharmaceutical products — biotechnology products and production technologies. The company supplies insulins to Brazil and transfers its proprietary recombinant insulin production technology.
Indar insulins are registered in Kazakhstan, Moldova, Syria, Yemen, Jordan and Iraq. The company is among the first to receive the National GMP Certificate and holds the Brazilian GMP certificate (ANVISA).
Indar is a very progressive, modern production facility that has reached tremendous heights in medicine manufacturing. I am confident that a long-term strategic partnership awaits our countries.
Carlos Gadelha, Head of the Secretariat of Science, Technology and Strategic Inputs, Ministry of Health of Brazil